The RecQ family of DNA helicases is widespread and highly conserved. Homologues in
Escherichia coli, budding and fission yeasts, Drosophila, and human WRN, BLM, and RECQ4 are the best characterized, and two additional human homologues, RECQ1 and RECQ5, are known (reviewed,
Bachrati and Hickson, 2003;
Wu and Hickson, 2006). Loss of function of some RecQ homologues results in chromosomal aberrations and genomic instability, including hyper-recombination, genome rearrangements, and in humans, cancer proneness (
Myung et al., 2001;
Saintigny et al., 2002;
Stewart et al., 1997; and reviewed,
Bachrati and Hickson, 2003). Loss of
BLM,
WRN, and
RECQ4 functions results in Bloom, Werner, and Rothmund-Thomson cancer-predisposition syndromes. In contrast, genome instability is not prominent in
E. coli recQ mutants. Instability was reported in
E. coli recQ cells expressing phage λ proteins (
Hanada et al., 1997), but not observed in the absence of λ (
Mashimo et al., 2003).
Despite the importance of RecQ-like proteins, their precise cellular role(s) remain uncertain. RecQ-like helicases unwind multiple substrates in vitro, and the most relevant for each in vivo are unclear. In vitro, 3′–5′ unwinding activity is reported on B-form DNA, Holliday junctions (HJ), forked structures (e.g., BLM, WRN, yeast Sgs1, RecQ), and G4 (tetraplex) DNA (e.g., BLM, Sgs1, RecQ) (reviewed,
Bachrati and Hickson, 2003; and see
Hishida et al., 2004). In vivo, possible roles in preventing or repairing stalled replication forks are suggested for RecQ and others (
Bjergbaek et al., 2005;
Courcelle and Hanawalt, 1999;
Doe et al., 2000;
Florés et al., 2005;
Hishida et al., 2004;
Wu and Hickson, 2006), though the precise role(s) in such processes is uncertain.
Nevertheless, for some RecQ-like proteins an overall “paradigm” to explain in vivo effects has emerged; several RecQ-like proteins reduce steady-state levels of bimolecular intermediates in homologous recombination (BRIs). BRIs can be toxic if not removed. For example, loss of WRN leads to reduced viability (and decreased mitotic recombination) that can be rescued either by expressing a bacterial HJ resolvase or by loss of RAD51, which catalyzes BRI formation (
Saintigny et al., 2002). Accumulated BRIs can block chromosome segregation, reducing viability. Viability is presumably restored by processing the BRIs by resolvase or by the loss of RAD51. Drosophila DmBLM appears to process BRIs in vivo (
McVey et al., 2004). Human BLM unwinds model BRIs in vitro (
Wu and Hickson, 2003).
S. pombe rqh1 mutants display chromosome-segregation defects that are suppressed by expressing a bacterial HJ resolvase (
Doe et al., 2000). Both in budding yeast and
S. pombe,
sgs1 srs2 (
rqh1 srs2 in
S. pombe) double mutants are inviable only if strand-exchange proteins Rad51, Rad55, and Rad57 are present, implying death by unresolved BRIs and failure of chromosome segregation (
Doe and Whitby, 2004;
Gangloff et al., 2000;
Liberi et al., 2005).
srs2, homologue of
E. coli uvrD discussed below, encodes a helicase that removes Rad51 from DNA, causing an apparent build-up of BRIs in its absence (
Krejci et al., 2003;
Veaute et al., 2003). The net cellular levels of BRIs could be reduced by these RecQ-like helicases in either of two ways: they might unwind problematic DNA structures that, if left, require recombinational DNA repair; or they might directly promote unwinding (reversal) or dissolution/resolution of BRIs formed in spontaneous DNA damage-repair events (
Bachrati and Hickson, 2003;
Wu and Hickson, 2006). Either way, net levels of BRIs are reduced. This in vivo paradigm does not exclude other possible roles for these proteins, or even that they might act at multiple stages in recombination. Here, we address whether
E. coli RecQ affects the overall outcome of recombination in vivo similarly.
E. coli RecQ has been hypothesized to act in various roles in DNA metabolism. RecQ promotes re-start of stalled replication forks in vivo (
Courcelle and Hanawalt, 1999), and in vitro unwinds the lagging-strand equivalent in model forks (
Hishida et al., 2004). Its role in replication re-start might be via recombination, via non-recombinational direct assistance at the replication fork (
Courcelle and Hanawalt, 1999), or indirectly via promotion of an SOS DNA damage response (
Hishida et al., 2004). In model partial reactions of recombination in vitro, RecQ can promote RecA-mediated strand-exchange (
Harmon and Kowalczykowski, 1998). Although this suggests a role in increasing net levels of BRIs in vivo, RecQ also catalyzes reactions compatible with reduction of BRI levels. RecQ stimulates strand-passage activity of Topoisomerase (Topo) III, leading to either catenation or decatenation of duplex DNA molecules (
Harmon et al., 1999). The decatenation activity resembles that of BLM with Topo III in resolution of model BRIs (
Wu and Hickson, 2003). This would suggest a role in net reduction of BRIs, also suggested on the basis of in vivo data (
Lopez et al., 2005, discussed below). Similarly, decatenation by RecQ and Topo III could serve additionally to decatenate and resolve interlinked bacterial chromosomes after recombination and HJ resolution (
Harmon et al., 1999), which would also support RecQ acting via the yeast/fly/WRN paradigm of net reduction of levels of BRIs in vivo. Alteration of DNA topology with Topo III might alternatively aid DNA replication-fork progression, not recombination. Finally, RecQ might promote both BRI formation and resolution in vivo. Which of these, if either, is its predominant role in vivo is examined here.
Here we present evidence that E. coli RecQ can promote the net accumulation of BRIs in vivo, the opposite of the paradigm shown for yeast, fly, and two human RecQ homologues. We suggest that this exemplifies a second paradigm for the net effect of a RecQ-family protein in vivo. This paradigm for E. coli RecQ might pertain to human RecQ homologues, perhaps other than BLM or WRN, for which the cellular roles are poorly defined.